ARCHITECT Methotrexate Extended Range Controls

Methotrexate · class III · Until 01/06/2035

Registration no.
80146501930
Process no.
25351773152201427
Status
Until 01/06/2035
Device type
Methotrexate (METOTREXATE)
Risk class
III
Registration holder
ABBOTT LABORATORIOS DO BRASIL LTDA CNPJ 56.998.701/0001-16 · 2,467 registrations
Manufacturer
ABBOTT GMBH · Germany
Published
01/06/2015
Valid until
01/06/2035
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other methotrexate registrations (8 in total, see all)

ProductClass HolderPublishedStatus
Metotrexato (MTX) - SNIBE
10303460618
III IN VITRO DIAGNOSTICA LTDA 24/08/2026 Until 24/08/2036
Família Methotrexate
10287411705
III ROCHE DIAGNÓSTICA BRASIL LTDA 21/10/2024 Until 21/10/2034
Família Alinity i Methotrexate
80146502269
III ABBOTT LABORATORIOS DO BRASIL LTDA 03/08/2020 Until 03/08/2030
ARCHITECT Methotrexate Controls
80146501928
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Calibrators
80146501929
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Reagent Kit
80146501923
III ABBOTT LABORATORIOS DO BRASIL LTDA 16/03/2015 Until 16/03/2035
EMIT - ENSAIO DE METOTREXATO
10345161293
III SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA 10/08/2009 Until 06/10/2033